These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21185330)

  • 1. Establishment and validation of an ELISA for the quantitation of HBsAg in recombinant hepatitis B vaccines.
    Costa CI; Delgado IF; da Costa JA; de Carvalho RF; Mouta Sda S; Vianna CO; de Moraes MT
    J Virol Methods; 2011 Mar; 172(1-2):32-7. PubMed ID: 21185330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an in-vitro method for Hepatitis B vaccine potency assay: specification setting.
    Karimzadeh H; Ajdary S; Jazayeri SM; Pakzad SR
    Panminerva Med; 2010 Sep; 52(3):177-82. PubMed ID: 21045773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers.
    Cuervo ML; Sterling AL; Nicot IA; Rodríguez MG; García OR
    Biologicals; 2008 Nov; 36(6):375-82. PubMed ID: 18693036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
    Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a new ELISA method for in vitro potency assay of hepatitis B-containing vaccines.
    Giffroy D; Mazy C; Duchêne M
    Pharmeuropa Bio; 2006 Nov; 2006(1):7-14. PubMed ID: 17270127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the diagnostic specificity and sensitivity of third generation tests by the detection of hepatitis B virus markers in the serum. I. HBsAg].
    Corridori S; Gorini P; Trespi G; Baldini E; Campisi D
    Boll Ist Sieroter Milan; 1985; 64(3):195-200. PubMed ID: 4041243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocapture enzyme-linked immunosorbent assay for assessment of in vitro potency of recombinant hepatitis B vaccines.
    Shanmugham R; Thirumeni N; Rao VS; Pitta V; Kasthuri S; Singanallur NB; Lingala R; Mangamoori LN; Villuppanoor SA
    Clin Vaccine Immunol; 2010 Aug; 17(8):1252-60. PubMed ID: 20592114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
    Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
    Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine.
    Cambron P; Jacquet JM; Hoet B; Lievens M
    Clin Vaccine Immunol; 2009 Aug; 16(8):1236-46. PubMed ID: 19553553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of a ultramicroELISA for detecting antibodies against hepatitis B surface antigen].
    Rodríguez L; Balmaseda A; Bravo J; Trujillo J; Martínez L; Ochoa R; Díaz M; Laferté J; Ramos F
    Rev Cubana Med Trop; 1996; 48(1):45-9. PubMed ID: 9768269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.
    Clark JR; Bartley K; Jepson CD; Craik V; March JB
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production and characterization of monoclonal antibodies directed against the hepatitis B surface antigen].
    Pujol FH; Rodríguez I; Liprandi F
    Acta Cient Venez; 1992; 43(4):235-9. PubMed ID: 1343738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of recombinant adeno-associated virus carrying hepatitis B surface antigen gene and preliminary study of the gene expression and function].
    Hu GF; Wu XB; Yu SY; Dong XY; Chen Q; Hou YD
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):553-6. PubMed ID: 12810373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA).
    Tsitsilonis OE; Thrasyvoulides A; Balafas A; Voutsas JF; Papamichail M; Lymberi P
    J Pharm Biomed Anal; 2004 Mar; 34(4):811-22. PubMed ID: 15019059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Western blot analysis of the reactivity between envelope proteins of hepatitis B viruses from Brazilian carriers and antibodies raised against recombinant hepatitis B vaccines.
    De Castro L; Yoshida CF; Gaspar AM; Gomes SA
    Acta Virol; 1996; 40(5-6):251-8. PubMed ID: 9171452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Yamaguchi K
    J Virol Methods; 2006 Sep; 136(1-2):254-6. PubMed ID: 16707169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies.
    Waters JA; Bailey C; Love C; Thomas HC
    J Med Virol; 1998 Jan; 54(1):1-6. PubMed ID: 9443102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological properties of recombinant HBsAg produced in yeast.
    Hauser P; Voet P; Simoen E; Thomas HC; Pêtre J; De Wilde M; Stephenne J
    Postgrad Med J; 1987; 63 Suppl 2():83-91. PubMed ID: 2446304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.